Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| bioAffinity Technologies, Inc. | 117,455 | reported | 01 Jul 2024 | tx 10+119,496 |
| ENTREMED INC | 55,000 | reported | 26 Jan 2010 | tx 10+356,393 |
| MEDICIS PHARMACEUTICAL CORP | 0 | reported | 11 Dec 2012 | tx 35+151,307−280,617 |
| PAR PHARMACEUTICAL COMPANIES, INC. | 0 | reported | 28 Sept 2012 | tx 67+82,543.6−111,372 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jul 2024 | GRANT_AWARD | bioAffinity Technologies, Inc. | 33,784 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | bioAffinity Technologies, Inc. | 8,296 | 0.00 USD | |
| 01 Oct 2023 | GRANT_AWARD | bioAffinity Technologies, Inc. | 11,867 | 1.58 USD | |
| 01 Jan 2024 | GRANT_AWARD | bioAffinity Technologies, Inc. | 12,668 | 1.48 USD | |
| 01 Jul 2023 | GRANT_AWARD | bioAffinity Technologies, Inc. | 10,245 | 1.83 USD | |
| 15 Apr 2023 | GRANT_AWARD | bioAffinity Technologies, Inc. | 9,920 | 1.89 USD | |
| 01 Jan 2023 | GRANT_AWARD | bioAffinity Technologies, Inc. | 8,227 | 2.28 USD | |
| 31 Aug 2022 | PURCHASE | bioAffinity Technologies, Inc. | 8,163 | — | |
| 31 Aug 2022 | PURCHASE | bioAffinity Technologies, Inc. | 8,163 | — | derivfirst after silence |
| 31 Aug 2022 | PURCHASE | bioAffinity Technologies, Inc. | 8,163 | — | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 12,532 | 44.00 USD | |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 15,000 | 28.11 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 15,000 | 11.44 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 6,842 | 7.71 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 21,000 | 4.96 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 7,743 | 6.15 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 15,000 | 20.38 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 7,500 | 11.65 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 15,000 | 10.19 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 15,000 | 21.21 USD | deriv |
| 11 Dec 2012 | OTHER | MEDICIS PHARMACEUTICAL CORP | 21,000 | 14.70 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 3,500 | 50.00 USD | |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 5,000 | 16.38 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 5,000 | 23.62 USD | deriv |
| 28 Sept 2012 | OTHER | PAR PHARMACEUTICAL COMPANIES, INC. | 22,782 | 50.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 31 Aug 2022.